These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28654364)

  • 1. Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    Leonard JP; Martin P; Roboz GJ
    J Clin Oncol; 2017 Aug; 35(23):2708-2715. PubMed ID: 28654364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Health Organization (WHO) classification of the myeloid neoplasms.
    Vardiman JW; Harris NL; Brunning RD
    Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
    Lynch RC; Gratzinger D; Advani RH
    Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some suggestion of using the world health organization classification of the acute myeloid leukemia in China].
    Da WM
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2105-7. PubMed ID: 15029885
    [No Abstract]   [Full Text] [Related]  

  • 6. The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
    Arber DA
    Semin Hematol; 2019 Apr; 56(2):90-95. PubMed ID: 30926096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemia.
    Heaney ML; Golde DW;
    Curr Oncol Rep; 2000 Mar; 2(2):140-3. PubMed ID: 11122835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
    Cucuianu A
    Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2016 revision of the WHO classification of lymphoid neoplasms].
    Tamaru JI
    Rinsho Ketsueki; 2017; 58(10):2188-2193. PubMed ID: 28978864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness and issue of the WHO classification of AMLs].
    Kuriyama K
    Rinsho Ketsueki; 2004 Jan; 45(1):6-14. PubMed ID: 14999929
    [No Abstract]   [Full Text] [Related]  

  • 11. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
    Tohda S
    Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms.
    Smith CA; Fan G
    Hum Pathol; 2008 Jun; 39(6):795-810. PubMed ID: 18538168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukaemia: How to combine multiple tools.
    Merino A; Boldú L; Ermens A
    Int J Lab Hematol; 2018 May; 40 Suppl 1():109-119. PubMed ID: 29741260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
    Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline for AML].
    Miyawaki S
    Rinsho Ketsueki; 2013 Oct; 54(10):1633-42. PubMed ID: 24064812
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
    Gao J; Gong S; Chen YH
    Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.